Pharma & Biopharma

What would it mean for science as a whole if the results of a seminal Alzheimer's paper underpinning the amyloid hypothesis were fabricated?

Putting COVID-19 on a diet, native ambient MS aids drug discovery, and elucidating monoclonal antibody structure with IMS-MS…

Combining fluorescence microscopy with flow cytometry to sort cells based on visual characteristics

How ion mobility-mass spectrometry could lead to improvements in bioprocessing efficiency

Mohsin El Amrani believes 2D-LC with HRAM-MS pave the way for bioanalytical quantification of next-generation therapeutic mAbs

Advanced analytical technologies now offer the detailed assessments biopharma drug developers need.

Our annual Mass Spectrometry Supplement explores application notes from leading companies spanning the breadth of MS research

If you want to avoid costly and reputation-damaging failed inspections, shut-downs or product recalls, maintaining data integrity is crucial

A spectroscopic near real-time PAT tool, saying “bye bye” to batch, and $100 million for Carol Robinson’s native mass spec tech…

How AI-enabled tools can democratize cell painting to speed up drug discovery and reduce failure rates